Abstract
The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses, as well as occult primary cancer, salivary gland cancer, and mucosal melanoma (MM). The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel’s most recent recommendations regarding management of nasopharynx cancer and ongoin research in this area
Cite
CITATION STYLE
Colevas, A. D., Cmelak, A. J., Pfister, D. G., Spencer, S., Adkins, D., Birkeland, A. C., … Darlow, S. D. (2025). Head and Neck Cancers, Version 2.2025. JNCCN Journal of the National Comprehensive Cancer Network, 23(2), 2–11. https://doi.org/10.6004/jnccn.2025.0007
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.